文献速递创伤与烧伤儿科与产科急症

英格兰青少年创伤流行病学:2008-2017年TARN数据回顾

Epidemiology of adolescent trauma in England: a review of TARN data 2008-2017.
PubMed 文献 · Emerg Med J · 2019-11-13
一句话结论2008-2017年英格兰40 680例10-24岁青少年创伤中,道路交通碰撞占50.3%、故意伤害占20.7%,总病死率4.1%。

该研究从创伤审计研究网络(TARN)提取英格兰站点2008-2017年共10年的数据,青少年定义为10-24岁,采用描述性统计分析,共记录40 680例青少年创伤。男性占77.3%、16-24岁占80.5%;报告病例年总数10年间增加2.6倍(p<0.0001),按每院每年单位创伤病例计算仍呈上升趋势(p=0.048)。道路交通碰撞为首位原因(50.3%),故意伤害占20.7%(其中疑似袭击17.2%、疑似自伤3.5%),刺伤占比由2008年6.9%升至2017年10.2%(p<0.0001)。收治于主要创伤中心的病例由2008年45.7%升至2017年63.5%(p<0.0001),总体病死率4.1%,有已知精神科诊断者病死率更高(6.3% vs 4.4%,p<0.001)。作者认为需优先采取国家层面预防性公共卫生措施和早期干预。

要点

  • 道路交通碰撞是青少年创伤首位原因(50.3%);10-15岁组以行人(41.2%)和骑行者(32.6%)为主,16-24岁组以驾驶员(22.9%)和乘客(17.8%)为主。
  • 故意伤害占20.7%(疑似袭击17.2%、疑似自伤3.5%),在16-24岁组更常见;刺伤占比由2008年6.9%升至2017年10.2%(p<0.0001)。
  • 10年间报告至TARN的青少年创伤年病例总数增加2.6倍(p<0.0001),按每院每年单位创伤病例计仍呈上升趋势(p=0.048)。
  • 收治于主要创伤中心的病例由2008年45.7%升至2017年63.5%(p<0.0001);总体病死率4.1%,有已知精神科诊断者病死率6.3% vs 4.4%(p<0.001)。
  • 20.1%病例记录有酒精或药物使用证据;创伤更常发生在08:00至00:00之间、周末及4月至10月。

适用人群与场景

  • 英格兰站点2008-2017年录入TARN的创伤病例,青少年定义为10-24岁(已完成年龄),共40 680例。
  • 10-15岁组与16-24岁组的受伤机制构成不同:前者以行人和骑行者为主,后者以驾驶员和乘客为主。

研究设计与关键结果

  • 研究类型为基于TARN数据库的10年数据回顾性描述性统计分析,纳入英格兰站点40 680例10-24岁青少年创伤病例。
  • 男性占77.3%,16-24岁占80.5%;报告病例年总数10年间增加2.6倍(p<0.0001),按每院每年单位创伤病例计呈上升趋势(p=0.048)。
  • 道路交通碰撞占50.3%;10-15岁组行人41.2%、骑行者32.6%,16-24岁组驾驶员22.9%、乘客17.8%。
  • 故意伤害占20.7%(疑似袭击17.2%、疑似自伤3.5%),在16-24岁组更常见;刺伤由2008年6.9%升至2017年10.2%(p<0.0001)。
  • 酒精或药物使用证据记录于20.1%的病例;创伤更常发生于08:00至00:00之间、周末和4月至10月。
  • 收治于主要创伤中心的比例由2008年45.7%升至2017年63.5%(p<0.0001);总体病死率4.1%,有已知精神科诊断者6.3% vs 4.4%(p<0.001)。

证据类型、等级与局限

  • 证据类型为基于TARN登记数据的描述性流行病学研究。
  • 作者在结论中提出,医疗卫生专业人员和政策制定者需要优先采取国家层面预防性公共卫生措施和早期干预,以降低这一脆弱年龄组的创伤发生率。

对床旁实践的改变

  • 作者认为,医疗卫生专业人员和政策制定者需优先采取国家层面预防性公共卫生措施和早期干预,以降低10-24岁人群创伤发生率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Trauma contributes significantly to adolescent morbidity and mortality. We aimed to ascertain the epidemiology of adolescent trauma to inform prevention strategies.

METHODS: Data were abstracted from TARN (Trauma Audit Research Network) from English sites over a 10-year period (2008-2017). Adolescents were defined as 10-24 completed years. Descriptive statistical analysis was used in this study.

RESULTS: There were 40 680 recorded cases of adolescent trauma. The majority were male (77.3%) and aged 16-24 years old (80.5%). There was a 2.6-fold increase during the study time frame (p<0.0001) in the total annual number of cases reported to TARN. To account for increasing hospital participation, the unit trauma cases per hospital per year was used, noting an increasing trend (p=0.048). Road traffic collision (RTC) was the leading cause of adolescent trauma (50.3%). Pedestrians (41.2%) and cyclists (32.6%) were more prevalent in the 10-15 year group, while drivers (22.9%) and passengers (17.8%) predominated in the 16-24 year group. Intentional injury was reported in 20.7% (alleged assault in 17.2% and suspected self-harm in 3.5%). This was more prevalent in the 16-24 year group. The proportion of trauma reported due to violence has increased with stabbings increasing from 6.9% in 2008 to 10.2% in 2017 (p<0.0001). Evidence of alcohol or drug use was recorded in 20.1% of cases. There was an increase in the number treated in major trauma centres (45.7% 2008 vs 63.5% 2017, p<0.0001). Trauma was more likely to occur between 08:00 and 00:00, at weekends and between April and October. Overall mortality rate was 4.1%. Those with a known psychiatric diagnosis had a higher mortality (6.3% vs 4.4%, p<0.001).

CONCLUSIONS: RTCs and intentional injuries are leading aetiologies. Healthcare professionals and policy-makers need to prioritise national preventative public health measures and early interventions to reduce the incidence of trauma in this vulnerable age group.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Roberts Z, Collins JA, James D, et al. Epidemiology of adolescent trauma in England: a review of TARN data 2008-2017. Emerg Med J. 2019. PMID: 31722885. doi:10.1136/emermed-2018-208329

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。